All Comments by Paul Coleman

  1. cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease.
  2. Neurofilament protein levels in CSF are increased in dementia.
  3. Cholinergic markers in elderly patients with early signs of Alzheimer disease.
  4. Overexpression of alpha-internexin causes abnormal neurofilamentous accumulations and motor coordination deficits in transgenic mice.
  5. Mitochondrial DNA mutations in Alzheimer's disease.
  6. Treatment of Alzheimer's disease. New developments.
  7. The magnitude of brain lipid peroxidation correlates with the extent of degeneration but not with density of neuritic plaques or neurofibrillary tangles or with APOE genotype in Alzheimer's disease patients.
  8. Aluminum but not iron treatment induces pro-oxidant events in the rat brain.
  9. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
  10. Sulcal variability in the Alzheimer's brain: correlations with cognition.
  11. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.
  12. Neuropathological assessment of the lesions of significance in vascular dementia.
  13. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease.
  14. A preliminary study of dietary aluminium intake and risk of Alzheimer's disease.
  15. Neuropathologic diagnosis of Alzheimer disease: consensus between practicing neuropathologists?